nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulpiride—CA12—Hydrochlorothiazide—nephrolithiasis	0.35	0.356	CbGbCtD
Sulpiride—CA9—Hydrochlorothiazide—nephrolithiasis	0.35	0.356	CbGbCtD
Sulpiride—CA2—Hydrochlorothiazide—nephrolithiasis	0.283	0.288	CbGbCtD
Sulpiride—CA2—collecting duct of renal tubule—nephrolithiasis	0.00442	0.563	CbGeAlD
Sulpiride—CA2—Erythrocytes take up carbon dioxide and release oxygen—AQP1—nephrolithiasis	0.00294	0.353	CbGpPWpGaD
Sulpiride—CA12—renal system—nephrolithiasis	0.000751	0.0957	CbGeAlD
Sulpiride—CA12—kidney—nephrolithiasis	0.000726	0.0926	CbGeAlD
Sulpiride—DRD3—Monoamine GPCRs—CHRM3—nephrolithiasis	0.000458	0.0548	CbGpPWpGaD
Sulpiride—CA2—nephron tubule—nephrolithiasis	0.000424	0.0541	CbGeAlD
Sulpiride—BCHE—nephron tubule—nephrolithiasis	0.000407	0.0518	CbGeAlD
Sulpiride—CA2—renal system—nephrolithiasis	0.000386	0.0492	CbGeAlD
Sulpiride—DRD3—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.000385	0.0461	CbGpPWpGaD
Sulpiride—CA2—kidney—nephrolithiasis	0.000373	0.0475	CbGeAlD
Sulpiride—CA2—cortex of kidney—nephrolithiasis	0.000363	0.0463	CbGeAlD
Sulpiride—DRD2—Monoamine GPCRs—CHRM3—nephrolithiasis	0.00035	0.042	CbGpPWpGaD
Sulpiride—DRD2—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.000294	0.0353	CbGpPWpGaD
Sulpiride—DRD3—GPCRs, Other—CHRM3—nephrolithiasis	0.000203	0.0244	CbGpPWpGaD
Sulpiride—DRD3—G alpha (i) signalling events—RGS14—nephrolithiasis	0.000195	0.0233	CbGpPWpGaD
Sulpiride—DRD2—G alpha (i) signalling events—RGS14—nephrolithiasis	0.000149	0.0179	CbGpPWpGaD
Sulpiride—CA6—Metabolism—GRHPR—nephrolithiasis	0.000133	0.0159	CbGpPWpGaD
Sulpiride—CA6—Metabolism—AGXT—nephrolithiasis	0.000119	0.0142	CbGpPWpGaD
Sulpiride—CA12—Metabolism—GRHPR—nephrolithiasis	0.000115	0.0138	CbGpPWpGaD
Sulpiride—CA12—Metabolism—AGXT—nephrolithiasis	0.000103	0.0123	CbGpPWpGaD
Sulpiride—CA6—Metabolism—SLC26A1—nephrolithiasis	0.000101	0.0121	CbGpPWpGaD
Sulpiride—CA6—Metabolism—APRT—nephrolithiasis	0.000101	0.0121	CbGpPWpGaD
Sulpiride—DRD3—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	8.83e-05	0.0106	CbGpPWpGaD
Sulpiride—CA2—Metabolism—GRHPR—nephrolithiasis	8.8e-05	0.0105	CbGpPWpGaD
Sulpiride—CA12—Metabolism—SLC26A1—nephrolithiasis	8.72e-05	0.0104	CbGpPWpGaD
Sulpiride—CA12—Metabolism—APRT—nephrolithiasis	8.72e-05	0.0104	CbGpPWpGaD
Sulpiride—CA2—Metabolism—AGXT—nephrolithiasis	7.84e-05	0.0094	CbGpPWpGaD
Sulpiride—DRD3—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	7.57e-05	0.00907	CbGpPWpGaD
Sulpiride—CA9—Metabolism—GRHPR—nephrolithiasis	7.42e-05	0.00888	CbGpPWpGaD
Sulpiride—CA6—Metabolism—AQP1—nephrolithiasis	7.18e-05	0.00861	CbGpPWpGaD
Sulpiride—DRD2—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	6.76e-05	0.0081	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—RGS14—nephrolithiasis	6.67e-05	0.00799	CbGpPWpGaD
Sulpiride—CA2—Metabolism—APRT—nephrolithiasis	6.67e-05	0.00799	CbGpPWpGaD
Sulpiride—CA2—Metabolism—SLC26A1—nephrolithiasis	6.67e-05	0.00799	CbGpPWpGaD
Sulpiride—CA9—Metabolism—AGXT—nephrolithiasis	6.61e-05	0.00792	CbGpPWpGaD
Sulpiride—CA6—Metabolism—CHRM3—nephrolithiasis	6.5e-05	0.00779	CbGpPWpGaD
Sulpiride—CA12—Metabolism—AQP1—nephrolithiasis	6.21e-05	0.00745	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—RGS14—nephrolithiasis	6.05e-05	0.00725	CbGpPWpGaD
Sulpiride—DRD2—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	5.79e-05	0.00694	CbGpPWpGaD
Sulpiride—DRD3—GPCR ligand binding—CHRM3—nephrolithiasis	5.76e-05	0.0069	CbGpPWpGaD
Sulpiride—CA12—Metabolism—CHRM3—nephrolithiasis	5.62e-05	0.00673	CbGpPWpGaD
Sulpiride—CA9—Metabolism—SLC26A1—nephrolithiasis	5.62e-05	0.00673	CbGpPWpGaD
Sulpiride—CA9—Metabolism—APRT—nephrolithiasis	5.62e-05	0.00673	CbGpPWpGaD
Sulpiride—DRD3—GPCR ligand binding—PTH—nephrolithiasis	5.27e-05	0.00631	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—RGS14—nephrolithiasis	5.1e-05	0.00611	CbGpPWpGaD
Sulpiride—CA2—Metabolism—AQP1—nephrolithiasis	4.75e-05	0.00569	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—RGS14—nephrolithiasis	4.63e-05	0.00555	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—DGKH—nephrolithiasis	4.5e-05	0.0054	CbGpPWpGaD
Sulpiride—DRD2—GPCR ligand binding—CHRM3—nephrolithiasis	4.41e-05	0.00528	CbGpPWpGaD
Sulpiride—CA2—Metabolism—CHRM3—nephrolithiasis	4.3e-05	0.00515	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—ADCY10—nephrolithiasis	4.21e-05	0.00504	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—GRHPR—nephrolithiasis	4.15e-05	0.00498	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—DGKH—nephrolithiasis	4.09e-05	0.0049	CbGpPWpGaD
Sulpiride—DRD2—GPCR ligand binding—PTH—nephrolithiasis	4.03e-05	0.00483	CbGpPWpGaD
Sulpiride—CA9—Metabolism—AQP1—nephrolithiasis	4e-05	0.0048	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—AGXT—nephrolithiasis	3.7e-05	0.00443	CbGpPWpGaD
Sulpiride—CA9—Metabolism—CHRM3—nephrolithiasis	3.62e-05	0.00434	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—RGS14—nephrolithiasis	3.58e-05	0.00429	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—DGKH—nephrolithiasis	3.45e-05	0.00413	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—CHRM3—nephrolithiasis	3.26e-05	0.0039	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—ADCY10—nephrolithiasis	3.22e-05	0.00386	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—SLC26A1—nephrolithiasis	3.15e-05	0.00377	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—APRT—nephrolithiasis	3.15e-05	0.00377	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—DGKH—nephrolithiasis	3.13e-05	0.00375	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—PTH—nephrolithiasis	2.98e-05	0.00357	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—CHRM3—nephrolithiasis	2.96e-05	0.00354	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—RGS14—nephrolithiasis	2.74e-05	0.00328	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—PTH—nephrolithiasis	2.7e-05	0.00324	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—CHRM3—nephrolithiasis	2.49e-05	0.00299	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—DGKH—nephrolithiasis	2.42e-05	0.00289	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—ATP6V0A4—nephrolithiasis	2.42e-05	0.00289	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—PTH—nephrolithiasis	2.28e-05	0.00273	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—CHRM3—nephrolithiasis	2.26e-05	0.00271	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—AQP1—nephrolithiasis	2.24e-05	0.00269	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—PTH—nephrolithiasis	2.07e-05	0.00248	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—CHRM3—nephrolithiasis	2.03e-05	0.00243	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—ATP6V0A4—nephrolithiasis	1.85e-05	0.00222	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—DGKH—nephrolithiasis	1.85e-05	0.00222	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—CHRM3—nephrolithiasis	1.75e-05	0.00209	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—PTH—nephrolithiasis	1.6e-05	0.00191	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—CHRM3—nephrolithiasis	1.34e-05	0.0016	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—PTH—nephrolithiasis	1.22e-05	0.00146	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—SPP1—nephrolithiasis	8.02e-06	0.000961	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—SPP1—nephrolithiasis	6.14e-06	0.000735	CbGpPWpGaD
